Table 3.
Baseline and final assessments for biological parameters in both groups.
| Variable | Control group (n = 20) | Intervention group (n = 21) | Changes observed for the intervention group compared to the control group | ||||
|---|---|---|---|---|---|---|---|
| Initial assessment | Final assessment | Initial assessment | Final assessment | Effect size (95% CI) | Rating | Chances of beneficial/trivial/detrimental effect (%) | |
| Systolic blood pressure (mmHg) | 148 ± 6 | 149.2 ± 5.1 | 147.5 ± 4.1 | 134.1 ± 5.2* | −2.77 (−3.48 to −2.07) | Large | 100/0/0 |
| Diastolic blood pressure (mmHg) | 80.5 ± 4.7 | 78.4 ± 3.4 | 78.8 ± 3.6 | 73 ± 3.6* | −0.87 (−1.40 to −0.34) | Large | 99/1/0 |
| C-reactive protein (mg/L) | 4.1 ± 1.1 | 4 ± 1.4 | 4.1 ± 1.3 | 4.1 ± 1.2 | 0.09 (−0.76 to 0.94) | Trivial | 40/36/25 |
| Hemoglobin (g/dL) | 10.1 ± 2 | 10 ± 1.6 | 10.2 ± 1.8 | 10.4 ± 1.7 | 0.17 (−0.58 to 0.91) | Trivial | 47/37/16 |
| Albumin (g/L) | 39.9 ± 3.7 | 40.4 ± 3.7 | 39.6 ± 3.5 | 40 ± 2.6 | −0.10 (−0.41 to 0.39) | Trivial | 17/68/15 |
| Total cholesterol (mmol/L) | 4.2 ± 0.4 | 4.1 ± 0.6 | 4 ± 0.5 | 3.9 ± 0.4 | −0.12 (1.10 to 0.87) | Trivial | 43/31/26 |
| HDL-cholesterol (mmol/L) | 1.3 ± 0.4 | 1.4 ± 0.4 | 1.2 ± 0.3 | 1.7 ± 0.4* | 1.15 (0.10 to 2.19) | Large | 96/3/1 |
| LDL-cholesterol (mmol/L) | 2.6 ± 0.5 | 2.5 ± 0.4 | 2.4 ± 0.3 | 1.9 ± 0.3* | −0.98 (−1.79 to −0.16) | Large | 97/3/0 |
| Triglycerides (mmol/L) | 1.9 ± 0.6 | 1.9 ± 0.5 | 1.9 ± 0.5 | 1.4 ± 0.4* | −1.01 (−1.83 to −0.19) | Large | 98/2/0 |
*
Significantly different from baseline (P < 0.05).